| Bioactivity | Autotaxin-IN-4 (compound 51), extracted from patent WO2018212534A1, is an Autotaxin inhibitor. Autotaxin-IN-4 has the potential to treat idiopathic pulmonary fibrosis[1]. |
| Name | Autotaxin-IN-4 |
| CAS | 2156655-86-4 |
| Formula | C22H21N9O2 |
| Molar Mass | 443.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. LEE, Dae Yon, et al. NOVEL COMPOUNDS AS AUTOTAXIN INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME. WO2018212534A1. |
Autotaxin-IN-4
CAS: 2156655-86-4 F: C22H21N9O2 W: 443.46
Autotaxin-IN-4 (compound 51), extracted from patent WO2018212534A1, is an Autotaxin inhibitor. Autotaxin-IN-4 has the po
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.